Interventional: Page 29

Cyclosporine during MI may limit reperfusion injury

By Reuters Health

NEW YORK (Reuters Health), Aug 4 - Administration of cyclosporine at the time of percutaneous coronary intervention for acute ST-elevation myocardial infarction (STEMI) appears to limit the size of the infarct, according to results of a small randomized trial in France.

August 3, 2008

Direct emergency admission to catheterization lab reduces time to intervention

By Reuters Health

NEW YORK (Reuters Health), Jul 23 - Direct ambulance admission to the cardiac catheterization laboratory significantly reduces the time to performance of primary percutaneous intervention, according to a report in the June issue of the American Heart Journal.

July 22, 2008

Routine clopidogrel before angiography no advantage in subsequent PCI

By Reuters Health

NEW YORK (Reuters Health), Jul 16 - In patients with stable angina who might be candidates for percutaneous coronary intervention, there appears to be no benefit to clopidogrel pretreatment before they undergo elective angiography. In fact, it may increase minor bleeding complications, according to Czech researchers.

July 15, 2008

Angiotech wins patent stamp of approval in U.K.

By AuntMinnieEurope.com staff writers

Medical device firm Angiotech Pharmaceuticals of Vancouver, British Columbia, received confirmation in the U.K. of the validity of one of its patents related to its paclitaxel stent inventions.

July 9, 2008

Xograph completes U.K. installations

By AuntMinnieEurope.com staff writers

U.K. radiology products supplier Xograph Healthcare has installed six new mobile Mobile DaRt digital x-ray systems and one new mobile Ziehm Vision R image intensifier at Barts and the London NHS Trust.

July 8, 2008

Siemens nets U.K. install

By AuntMinnieEurope.com staff writers

Siemens Healthcare's angiography system has been selected by a U.K. lung and heart center, according to the Malvern, PA-based company.

June 24, 2008

PLC Systems to begin CIN clinical trial

By AuntMinnieEurope.com staff writers

PLC Systems of Franklin, MA, has received approval from the Centro Cardiologico Monzino of Milan, Italy, for a randomized clinical trial to evaluate the use of its RenalGuard product.

May 29, 2008

BioSphere nets CE Mark OK

By AuntMinnieEurope.com staff writers

Interventional device developer BioSphere Medical has received the European CE Mark for transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) using its HepaSphere microspheres.

December 17, 2007

Medtronic begins Endurant trial

By AuntMinnieEurope.com staff writers

Interventional technology firm Medtronic has begun the first human study of its Endurant stent graft system for the treatment of abdominal aortic aneurysm (AAA).

December 16, 2007

Cordis partners with Volcano in Europe

By AuntMinnieEurope.com staff writers

The European divisions of interventional device firm Cordis of Waterloo, Belgium, and intravascular ultrasound (IVUS) developer Volcano have signed a deal to market IVUS technology to European hospitals.

November 11, 2007

Drug-eluting stents not cost-effective if used in all patients

By Reuters Health

NEW YORK (Reuters Health), Nov 2 - In the long-term, drug-eluting stents (DES) are not a good value for the money if used in all patients with coronary artery disease, according to a report in the November 3rd issue of the Lancet.

November 1, 2007

Advanced liver imaging shapes surgical strategies

By Eric Barnes

The days of planning liver interventions on the strength of a few CT or MR reconstructions may be numbered. Researchers from Germany and beyond are honing a set of advanced planning tools that not only provide high-resolution color-coded 3D visualization of the liver parenchyma and vasculature, but offer quantitative views of the intrahepatic vessel branching system and the risks of cutting at a given point in the organ.

September 17, 2007

Previous Page

Page 29 of 32

Next Page